Skip to content

EV / EBITDA at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
21.3×-3.5×
Labcorp Holdings logo
Labcorp HoldingsLH
13.3×-1.4×
IQVIA logo
IQVIAIQV
12.1×-0.6×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
19×+3.3×
Veeva Systems logo
Veeva SystemsVEEV
15.8×-11.3×
Arrowhead Research logo
Arrowhead ResearchARWR
27.4×

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Calculated from Medpace Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s EV / EBITDA?
Medpace Holdings, Inc. (MEDP) reported EV / EBITDA of 22.2× in Q1 2026.
How has Medpace Holdings, Inc.'s EV / EBITDA changed year-over-year?
Medpace Holdings, Inc.'s EV / EBITDA increased by 19.9% year-over-year, from 18.5× to 22.2×.
What is the long-term trend for Medpace Holdings, Inc.'s EV / EBITDA?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s EV / EBITDA has grown at a 1.1% compound annual growth rate (CAGR), from 26× to 27.5×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.